Amrize (AMRZ) closed at $39.44 on October 23, 2026, unchanged from the previous close, on volume of 4,392,201 shares (30-day average 3,389,174).
Data as of October 23, 2026.
Amrize Ltd (AMRZ) Gets a Hold from Barclays
TipRanks (Sun, 18-Oct 9:15 PM ET)
Amrize Announces Date for Third Quarter 2026 Financial Results
Business Wire (Wed, 14-Oct 9:00 AM ET)
Amrize Appoints Mario Gross as President of Building Envelope
Business Wire (Fri, 11-Sep 4:15 PM ET)
Amrize Appoints Sam Poletti as Chief Financial Officer
Business Wire (Mon, 24-Aug 4:15 PM ET)
Amrize Files Form 10-Q for Second Quarter 2026
Business Wire (Mon, 10-Aug 4:15 PM ET)
Amrize Reports Second Quarter 2026 Results
Business Wire (Thu, 6-Aug 4:50 PM ET)
Amrize Expands Texas Presence with Rapid Redi-Mix Acquisition, Deepening Market Synergies
Market Chameleon (Mon, 20-Jul 5:17 AM ET)
Amrize Drives Montreal Cement Plant to Top Sustainability and Capacity in Eastern Canada
Market Chameleon (Mon, 22-Jun 3:08 AM ET)
Amrize Unveils $1 Billion Buyback—Signal of Confidence and Shareholder Value Focus
Market Chameleon (Tue, 5-May 3:11 AM ET)
Amrize is a North America-focused building solutions company formed in 2025 following its spinoff from Holcim. Its product portfolio spans cement, aggregates, ready-mix concrete, asphalt, roofing, and wall systems. It serves the infrastructure, commercial, and residential construction markets.
Amrize trades on the NYSE stock market under the symbol AMRZ.
As of October 23, 2026, AMRZ stock price was flat at $39.44 with 4,392,201 million shares trading.
AMRZ has a beta of 0.79, meaning it tends to be less sensitive to market movements. AMRZ has a correlation of 0.08 to the broad based SPY ETF.
AMRZ has a market cap of $21.57 billion. This is considered a Large Cap stock.
Last quarter Amrize reported $3 billion in Revenue and $.88 earnings per share. This beat revenue expectation by $153 million and missed earnings estimates by -$.11.
The top ETF exchange traded funds that AMRZ belongs to (by Net Assets): VXF, PAVE, VAW, IFRA, ITOT.
AMRZ has underperformed the market in the last year with a return of -16.0%, while the SPY ETF gained +14.9%. In the last 3 month period, AMRZ fell short of the market, returning -20.0%, while SPY returned +1.9%. However, in the most recent 2 weeks AMRZ has outperformed the stock market by returning +8.1%, while SPY returned -1.8%.
AMRZ support price is $38.82 and resistance is $40.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMRZ shares will trade within this expected range on the day.
